Literature DB >> 31875859

Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.

Bettina Toth1, Dunja Maria Baston-Büst2, Hermann M Behre3, Alexandra Bielfeld2, Michael Bohlmann4, Kai Bühling5, Ralf Dittrich6, Maren Goeckenjan7, Katharina Hancke8, Sabine Kliesch9, Frank-Michael Köhn10, Jan Krüssel2, Ruben Kuon11, Jana Liebenthron2, Frank Nawroth12, Verena Nordhoff13, Germar-Michael Pinggera14, Nina Rogenhofer15, Sabine Rudnik-Schöneborn16, Hans-Christian Schuppe17, Andreas Schüring18, Vanadin Seifert-Klauss19, Thomas Strowitzki11, Frank Tüttelmann20, Kilian Vomstein1, Ludwig Wildt1, Tewes Wischmann21, Dorothea Wunder22, Johannes Zschocke16.   

Abstract

Introduction Supporting and counselling couples with fertility issues prior to starting ART is a multidisciplinary diagnostic and therapeutic challenge. The first German-language interdisciplinary S2k guideline on "Diagnosis and Therapy Before Assisted Reproductive Treatments (ART)" was published in February 2019. The guideline was developed in the context of the guidelines program of the German Society of Gynecology and Obstetrics (DGGG) in cooperation with the Swiss Society of Gynecology and Obstetrics (SGGG) and the Austrian Society of Gynecology and Obstetrics (OEGGG). Aim In one third of cases, the cause of involuntary childlessness remains unclear, even if the woman or man have numerous possible risk factors. Because the topic is still very much taboo, couples may be socially isolated and often only present quite late to a fertility center. There is no standard treatment concept for these patients at present, as there are currently no standard multidisciplinary procedures for the diagnostic workup and treatment of infertility. The aim of this guideline is to provide physicians with evidence-based recommendations for counselling, diagnosis and treatment. Methods This S2k guideline was developed on behalf of the Guidelines Commission of the DGGG by representative members from different professional medical organizations and societies using a structured consensus process. Recommendations This second part of the guideline describes the hematological workup for women as well as additional diagnostic procedures which can be used to investigate couples and which are carried out in cooperation with physicians working in other medical fields such as andrologists, geneticists and oncologists. © Thieme Medical Publishers.

Entities:  

Keywords:  andrology; genetics; guideline; infertility; oncology; preconception counselling

Year:  2019        PMID: 31875859      PMCID: PMC6924330          DOI: 10.1055/a-1017-3478

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  29 in total

1.  Effects and effectiveness of heparin in assisted reproduction.

Authors:  Michael K Bohlmann
Journal:  J Reprod Immunol       Date:  2011-06-08       Impact factor: 4.054

2.  Prolonged activation of the coagulation system during in vitro fertilization cycles.

Authors:  Yoni Cohen; Togas Tulandi; Benny Almog; Eyal Zohav; Varda Deutsch; Ariel Many; Ami Amit; Aviad Cohen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2017-07-17       Impact factor: 2.435

Review 3.  The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.

Authors:  Jason M Franasiak; Eric J Forman; Kathleen H Hong; Marie D Werner; Kathleen M Upham; Nathan R Treff; Richard T Scott
Journal:  Fertil Steril       Date:  2013-12-17       Impact factor: 7.329

4.  Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis.

Authors:  Jay D Raman; Craig F Nobert; Marc Goldstein
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

5.  Experts' Opinion on the Prenatal Therapy of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency - Guideline of DGKED in cooperation with DGGG (S1-Level, AWMF Registry No. 174/013, July 2015).

Authors:  H G Dörr; G Binder; N Reisch; U Gembruch; P G Oppelt; P Wieacker; J Kratzsch
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

Review 6.  The genetic basis of female reproductive disorders: etiology and clinical testing.

Authors:  Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

Review 7.  Testicular microlithiasis and carcinoma in situ overview and proposed clinical guideline.

Authors:  N J van Casteren; L H J Looijenga; G R Dohle
Journal:  Int J Androl       Date:  2008-12-22

8.  Fertility information needs and concerns post-treatment contribute to lowered quality of life among young adult female cancer survivors.

Authors:  Catherine Benedict; Bridgette Thom; Danielle N Friedman; Elaine Pottenger; Nirupa Raghunathan; Joanne F Kelvin
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

Review 9.  Genetics of primary ovarian insufficiency: new developments and opportunities.

Authors:  Yingying Qin; Xue Jiao; Joe Leigh Simpson; Zi-Jiang Chen
Journal:  Hum Reprod Update       Date:  2015-08-04       Impact factor: 15.610

Review 10.  The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.

Authors:  Christopher L R Barratt; Lars Björndahl; Christopher J De Jonge; Dolores J Lamb; Francisco Osorio Martini; Robert McLachlan; Robert D Oates; Sheryl van der Poel; Bianca St John; Mark Sigman; Rebecca Sokol; Herman Tournaye
Journal:  Hum Reprod Update       Date:  2017-11-01       Impact factor: 15.610

View more
  2 in total

1.  A systematic review of the validated monogenic causes of human male infertility: 2020 update and a discussion of emerging gene-disease relationships.

Authors:  Brendan J Houston; Antoni Riera-Escamilla; Margot J Wyrwoll; Albert Salas-Huetos; Miguel J Xavier; Liina Nagirnaja; Corinna Friedrich; Don F Conrad; Kenneth I Aston; Csilla Krausz; Frank Tüttelmann; Moira K O'Bryan; Joris A Veltman; Manon S Oud
Journal:  Hum Reprod Update       Date:  2021-12-21       Impact factor: 15.610

2.  A systematic review and standardized clinical validity assessment of genes involved in female reproductive failure.

Authors:  Ludmila Volozonoka; Anna Miskova; Liene Kornejeva; Inga Kempa; Veronika Bargatina; Linda Gailite
Journal:  Reproduction       Date:  2022-04-22       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.